Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 7, 2007 - Issue 4
Submit an article Journal homepage
147
Views
3
CrossRef citations to date
0
Altmetric
Drug Profile

The cost–effectiveness of rituximab in non-Hodgkin’s lymphoma

Christopher Knight RTI-Health Solutions, Williams House, Manchester Science Park, Lloyd Street North, Manchester, M15 6SE, UK. [email protected]
&
Fiona Maciver Health Economics and Outcomes Research, IMS Health, 109 Hammersmith Road, London, W14 0QH, UK. [email protected]
Pages 319-326 | Published online: 09 Jan 2014

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Karissa M Johnston, Corneliu Bolbocean, Joseph Connors & Stuart Peacock. (2012) Cost–effectiveness of rituximab in follicular lymphoma. Expert Review of Pharmacoeconomics & Outcomes Research 12:5, pages 569-577.
Read now

Articles from other publishers (2)

Jian-Qiu Wu, Yong-Ping Song, Li-Ping Su, Ming-Zhi Zhang, Wei Li, Yu Hu, Xiao-Hong Zhang, Yu-Huan Gao, Zuo-Xing Niu, Ru Feng, Wei Wang, Jie-Wen Peng, Xiao-Lin Li, Xue-Nong Ouyang, Chang-Ping Wu, Wei-Jing Zhang, Yun Zeng, Zhen Xiao, Ying-Min Liang, Yong-Zhi Zhuang, Ji-Shi Wang, Zi-Min Sun, Hai Bai, Tong-Jian Cui & Ji-Feng Feng. (2018) Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China. Chinese Medical Journal 131:15, pages 1767-1775.
Crossref
Han-I. Wang, Alexandra Smith, Eline Aas, Eve Roman, Simon Crouch, Cathy Burton & Russell Patmore. (2016) Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort. The European Journal of Health Economics 18:2, pages 255-267.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.